« Return to News | Drug Sponsors

Hikma upbeat despite turbulence in Egypt, Libya and Tunisia

Thursday, March 17, 2011 12:41 PM

Jordanian drugmaker Hikma Pharmaceuticals has posted strong results for 2010, but political and social unrest in North Africa could hurt this year's earnings, according to PharmaTimes.

Operating profit was $135.1 million, up 25.9%, while revenues rose 14.8% to $730.9 million. The increases were due to strong growth in Hikma’s key market, the Middle East and North Africa (MENA) region, which makes up 61% of its revenues.

The company's branded business performed well, particularly in Algeria, Egypt, Saudi Arabia and across the other Gulf Cooperation Council countries, while its injectables arm was boosted by a 75.9% leap in sales in the U.S. Hikma said the injectables business will be "transformed" and sales should double once it completes its $112 million acquisition of the U.S. generic injectables unit of Baxter Healthcare.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.